CoChat

Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer

Open access
Renehan, Andrew G, Dwyer O', Sarah T, Whynes, David K · 2004 · BMJ
Cited by 112

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Objective To determine the cost effectiveness of intensive follow up compared with conventional follow up in patients with colorectal cancer. Design Incremental cost effectiveness analysis recognising differences in follow up strategies, based on effectiveness data from a meta-analysis of five randomised trials. Setting United Kingdom. Main outcome measures Taking a health service perspective, estimated incremental costs effectiveness ratios for each life year gained for five trials and four trials designed for early detection of extramural recurrences (targeted surveillance). Results Based on five year follow up, the numbers of life years gained by intensive follow up were 0.73 for the five trial model and 0.82 for the four trial model. For the five trials, the adjusted net (extra) cost for each patient was £2479 (€3550; $4288) and for each life year gained was £3402, substantially lower than the current threshold of NHS cost acceptability (£30 000). The corresponding values for the four trial model were £2529 and £3077, suggesting that targeted surveillance is more cost effective. The main predictor of incremental cost effectiveness ratios was surveillance costs rather than treatment costs. Judged against the NHS threshold of cost acceptability, the predicted incremental cost threshold was ninefold and the effectiveness threshold was 3%. Conclusions Based on the available data and current costs, intensive follow up after curative resection for colorectal cancer is economically justified and should be normal practice. There is a continuing need to evaluate the efficacy of specific surveillance tools: this study forms the basis for economic evaluations in such trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.328.7431.81

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 34

  1. Kievit, 1995, Detection of recurrence after surgery for colorectal cancer., Eur J Cancer, 31, 1222, 10.1016/0959-8049(95)00155-C · DOI
  2. Scholefield, 2002, Guidelines for follow up after resection of colorectal cancer., Gut, 51, V3, 10.1136/gut.51.suppl_5.v3 · DOI
  3. 10.1136/bmj.324.7341.813 · DOI · Paper page
  4. Jeffrey GM Hickey BE Hider P . Follow-up strategies for patients treated for non-metastatic colorectal cancer. In: Cochrane Library, Issue 1. Oxford: Update Software, 2002. · DOI · Paper page
  5. 10.1053/ejso.2001.1250 · DOI · Paper page
  6. Mella, 1997, Surgeons' follow-up practice after resection of colorectal cancer., Ann R Coll Surg Engl, 79, 206
  7. Bruinvels, 1995, Follow-up after colorectal cancer: current practice in the Netherlands., Eur J Surg, 161, 827
  8. 10.1007/BF02307079 · DOI
  9. 10.1001/archsurg.1995.01430100040009 · DOI · Paper page
  10. 10.1007/BF02054122 · DOI · Paper page
  11. 10.1016/S0016-5085(98)70626-2 · DOI · Paper page
  12. 10.1007/BF02239434 · DOI · Paper page
  13. 10.1002/bjs.1800840523 · DOI · Paper page
  14. 10.1136/bmj.323.7310.423 · DOI
  15. 10.1136/bmj.325.7373.1135 · DOI · Paper page
  16. 10.1016/S0140-6736(02)08268-5 · DOI · Paper page
  17. 10.1056/NEJMoa021633 · DOI · Paper page
  18. Kievit, 2002, Follow-up of patients with colorectal cancer: numbers needed to test and treat., Eur J Cancer, 38, 986, 10.1016/S0959-8049(02)00061-8 · DOI · Paper page
  19. 10.1046/j.1463-1318.2003.00410.x · DOI
  20. 10.1007/BF02235044 · DOI · Paper page
  21. 10.1136/bmj.323.7324.1300 · DOI · Paper page
  22. Torgerson, 1999, Economics notes: discounting., BMJ, 319, 914, 10.1136/bmj.319.7214.914 · DOI
  23. 10.1001/jama.1995.03520470045030 · DOI · Paper page
  24. 10.1023/A:1008265614183 · DOI
  25. 10.1046/j.1525-1497.1997.012005318.x · DOI
  26. 10.1097/00000658-199807000-00009 · DOI · Paper page
  27. Beart, 2000, Follow-up: does it work? Can we afford it?, Surg Oncol Clin N Am, 9, 827, 10.1016/S1055-3207(18)30122-4 · doi:10.1016/s1055-3207(18)30122-4
  28. Van den Hout, 2002, Cost-effectiveness analysis of colorectal cancer treatments., Eur J Cancer, 38, 953, 10.1016/S0959-8049(02)00053-9 · DOI
  29. Stiggelbout, 1997, Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up., Br J Cancer, 75, 914, 10.1038/bjc.1997.161 · DOI · Paper page
  30. Renehan AG Egger M Saunders MP Whynes D O'Dwyer ST . Intensive follow-up after colorectal cancer. Recent successes and future challenges. In: Cunningham D Topham C Miles A eds. The effective management of colorectal cancer, 4th ed.. London: Aesculapius Medical Press,.
  31. 10.1023/A:1008999403069 · DOI
  32. 10.1002/(SICI)1099-1050(199802)7:1<21::AID-HEC306>3.0.CO;2-9 · DOI
  33. 10.1080/003655299750026254 · DOI · Paper page
  34. 10.1136/jms.6.3.119 · DOI

Cited by

See all 112

Metadata

Authors
Renehan, A. G., Dwyer O', S. T., & Whynes, D. K.
Venue
BMJ
Publisher
BMJ
Published
2004-01-08
Volume
328
Issue
7431
Pages
81
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2142247257
Cited by
112
References
1
FWCI
22.92
Type
journal article
Language
en
Open access
bronze
Licence
www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.